These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
400 related items for PubMed ID: 12520356
1. Studies on the radioprotective potency of amifostine on salivary glands of rats during fractionated irradiation: acute and late effects. Sagowski C, Wenzel S, Metternich FU, Kehrl W. Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):42-7. PubMed ID: 12520356 [Abstract] [Full Text] [Related]
2. [Reducing late toxicity with amifostine in fractionated irradiation of the rat salivary glands]. Sagowski C, Wenzel S, Jenicke L, Bohuslavizki KH, Kehrl W, Zywietz F, Roeser K. HNO; 2002 Sep; 50(9):822-8. PubMed ID: 12425136 [Abstract] [Full Text] [Related]
3. [Radioprotective effectiveness of amifostine on the salivary glands of the rat during fractionated irradiation]. Sagowski C, Wenzel S, Neumann B, Kehrl W, Zywietz F, Roeser K, Ussmüller J. HNO; 2002 Feb; 50(2):139-45. PubMed ID: 12080624 [Abstract] [Full Text] [Related]
4. [Side effects of postoperative radiochemotherapy with amifostine versus radiochemotherapy alone in head and neck tumors. Preliminary results of a prospective randomized trial]. Vacha P, Marx M, Engel A, Richter E, Feyerabend T. Strahlenther Onkol; 1999 Nov; 175 Suppl 4():18-22. PubMed ID: 10584135 [Abstract] [Full Text] [Related]
5. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer. Thorstad WL, Chao KS, Haughey B. Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516 [Abstract] [Full Text] [Related]
6. Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection? Vacha P, Fehlauer F, Mahlmann B, Marx M, Hinke A, Sommer K, Richter E, Feyerabend T. Strahlenther Onkol; 2003 Jun; 179(6):385-9. PubMed ID: 12789464 [Abstract] [Full Text] [Related]
7. Intraoral manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) radioprotective gene therapy decreases ionizing irradiation-induced murine mucosal cell cycling and apoptosis. Epperly MW, Carpenter M, Agarwal A, Mitra P, Nie S, Greenberger JS. In Vivo; 2004 Jun; 18(4):401-10. PubMed ID: 15369176 [Abstract] [Full Text] [Related]
8. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing. Rosenthal DI, Chambers MS, Weber RS, Eisbruch A. Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519 [Abstract] [Full Text] [Related]
9. The radioprotectors amifostine and sodium selenite do not modify the radiosensitivity of rat rhabdomyosarcomas. Sagowski C, Tesche S, Zywietz F, Wenzel S, Metternich FU. Onkologie; 2004 Feb; 27(1):54-7. PubMed ID: 15007249 [Abstract] [Full Text] [Related]
10. Tissue-protective effects of fullerenol C60(OH)24 and amifostine in irradiated rats. Trajković S, Dobrić S, Jaćević V, Dragojević-Simić V, Milovanović Z, Dordević A. Colloids Surf B Biointerfaces; 2007 Jul 01; 58(1):39-43. PubMed ID: 17317115 [Abstract] [Full Text] [Related]
11. Sodium selenite is a potent radioprotector of the salivary glands of the rat: acute effects on the morphology and parenchymal function during fractioned irradiation. Sagowski C, Wenzel S, Jenicke L, Metternich FU, Jaehne M. Eur Arch Otorhinolaryngol; 2005 Jun 01; 262(6):459-64. PubMed ID: 15942798 [Abstract] [Full Text] [Related]
12. Effect of Amifostine to prevent radiotherapy-induced acute and late toxicity in head and neck cancer patients who had normal or mild impaired salivary gland function. Veerasarn V, Phromratanapongse P, Suntornpong N, Lorvidhaya V, Sukthomya V, Chitapanarux I, Tesavibul C, Swangsilpa T, Khorprasert C, Shotelersuk K, Kongthanarat Y, Panichevaluk A, Chiewvit S, Pusuwan P, Aekmahachai M, Ratchadara S, Sirilipoche S, Saengsuda Y. J Med Assoc Thai; 2006 Dec 01; 89(12):2056-67. PubMed ID: 17214057 [Abstract] [Full Text] [Related]
13. Amifostine is a potent radioprotector of salivary glands in radioiodine therapy. Structural and ultrastructural findings. Kutta H, Kampen U, Sagowski C, Brenner W, Bohuslavizki KH, Paulsen F. Strahlenther Onkol; 2005 Apr 01; 181(4):237-45. PubMed ID: 15827693 [Abstract] [Full Text] [Related]
14. [Sodium selenite reduces acute radiogenic damage of the rat parotid glands during fractionated irradiation]. Sagowski C, Wenzel S, Tesche S, Jenicke L, Kehrl W, Roeser K, Metternich FU. HNO; 2004 Dec 01; 52(12):1067-75. PubMed ID: 15597168 [Abstract] [Full Text] [Related]
15. Assessment of the protective effect of amifostine on radiation-induced pulmonary toxicity. Vujaskovic Z, Feng QF, Rabbani ZN, Samulski TV, Anscher MS, Brizel DM. Exp Lung Res; 2002 Dec 01; 28(7):577-90. PubMed ID: 12396250 [Abstract] [Full Text] [Related]
16. A prospective study of salivary gland function in lymphoma patients receiving head and neck irradiation. Rodrigues NA, Killion L, Hickey G, Silver B, Martin C, Stevenson MA, Mauch PM, Ng AK. Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):1079-83. PubMed ID: 19327910 [Abstract] [Full Text] [Related]
17. Investigation of radiosialadenitis during fractioned irradiation: sialoscintigraphical and histomorphological findings in rats. Sagowski C, Wenzel S, Tesche S, Jenicke L, Jaehne M. Eur Arch Otorhinolaryngol; 2003 Oct 15; 260(9):513-7. PubMed ID: 12761639 [Abstract] [Full Text] [Related]
18. Amifostine--a radioprotector in locally advanced head and neck tumors. Schönekäs KG, Wagner W, Prott FJ. Strahlenther Onkol; 1999 Nov 15; 175 Suppl 4():27-9. PubMed ID: 10584137 [Abstract] [Full Text] [Related]
19. A comparative study on the protection profile of lidocaine, amifostine, and pilocarpin on the parotid gland during radiotherapy. Hakim SG, Kosmehl H, Lauer I, Nadrowitz R, Wedel T, Sieg P. Cancer Res; 2005 Nov 15; 65(22):10486-93. PubMed ID: 16288041 [Abstract] [Full Text] [Related]
20. Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma. Bourhis J, Rosine D. Semin Oncol; 2002 Dec 15; 29(6 Suppl 19):61-2. PubMed ID: 12577247 [Abstract] [Full Text] [Related] Page: [Next] [New Search]